Cape Biology: One of the actual controllers, Wang Jianyu's increase holding plan has implemented more than half of the time.

Kai Pu Bioscience announced that one of the company's actual controllers, director and general manager Wang Jianyu, based on his confidence in the company's development, originally planned to increase his holdings of the company's shares through block trading with his own funds, not less than 12 million yuan worth, within 6 months starting from January 13, 2026. As of April 12th, more than half of the implementation time has passed, Wang Jianyu has accumulated 1.9 million shares through block trading, accounting for 0.29% of the total share capital, with an increase of 8.7223 million yuan and an average price of 4.59 yuan per share. After the increase, Wang Jianyu and his concerted action parties collectively hold 33.05% of the total share capital. This increase plan may be delayed or not be completed due to market changes.